Breaking News

PCI Pharma Services Completes LSNE Acquisition

Adds cGMP aseptic fill-finish capabilities and expertise in lyophilization, an important manufacturing process for injectable and biologic therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PCI Pharma Services has completed the previously announced acquisition of Lyophilization Services of New England, Inc. (LSNE), a contract development and manufacturing organization (CDMO) headquartered in Bedford, New Hampshire.   LSNE serves global pharmaceutical, biotechnology and medical device companies, offering cGMP aseptic fill-finish capabilities and expertise in and ability to scale lyophilization, an important manufacturing process commonly used with injectable and biologic therapies...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters